Financials Zhejiang Jolly Pharmaceutical Co.,LTD

Equities

300181

CNE100001096

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-06-17 EDT 5-day change 1st Jan Change
15.88 CNY -0.13% Intraday chart for Zhejiang Jolly Pharmaceutical Co.,LTD +1.47% +48.97%

Valuation

Fiscal Period: December 2020 2021 2023 2024 2025 2026
Capitalization 1 3,591 7,097 7,477 11,138 - -
Enterprise Value (EV) 1 3,591 7,097 7,477 11,138 11,138 11,138
P/E ratio 40.8 x 39.7 x 19.4 x 20.4 x 16.7 x 13.7 x
Yield - - 4.22% 3.97% 4.85% 5.92%
Capitalization / Revenue - - 3.85 x 4.24 x 3.45 x 2.75 x
EV / Revenue - - 3.85 x 4.24 x 3.45 x 2.75 x
EV / EBITDA - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - 2.74 x 3.66 x 3.39 x 3.11 x
Nbr of stocks (in thousands) 608,625 608,625 701,387 701,387 - -
Reference price 2 5.900 11.66 10.66 15.88 15.88 15.88
Announcement Date 21-03-09 22-03-09 24-03-12 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - 1,942 2,629 3,232 4,056
EBITDA - - - - - - -
EBIT 1 - - - 448.7 640 775 945
Operating Margin - - - 23.1% 24.34% 23.98% 23.3%
Earnings before Tax (EBT) 1 - - 3,409 446.6 634 769 939
Net income 1 87.96 178.7 2,917 382.9 546.5 663.8 810.9
Net margin - - - 19.71% 20.79% 20.54% 19.99%
EPS 2 0.1445 0.2937 - 0.5500 0.7800 0.9500 1.160
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - 0.4500 0.6300 0.7700 0.9400
Announcement Date 21-03-09 22-03-09 23-03-14 24-03-12 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - - - 13.8% 17.9% 20.2% 22.7%
ROA (Net income/ Total Assets) - - - - 13.8% 14.8% 15.8%
Assets 1 - - - - 3,960 4,485 5,132
Book Value Per Share 2 - - - 3.890 4.340 4.690 5.110
Cash Flow per Share 2 - - - 0.4100 0.9500 0.9900 1.160
Capex 1 - - - 129 17 62 42
Capex / Sales - - - 6.66% 0.65% 1.92% 1.04%
Announcement Date 21-03-09 22-03-09 23-03-14 24-03-12 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.88
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300181 Stock
  4. Financials Zhejiang Jolly Pharmaceutical Co.,LTD